Weaver C. Barksdale & Associates’s Vectren Corporation VVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$14K Buy
217
+13
+6% +$873 0.01% 224
2017
Q3
$13K Sell
204
-8
-4% -$501 0.01% 225
2017
Q2
$12K Sell
212
-13
-6% -$780 0.01% 241
2017
Q1
$13K Sell
225
-32
-12% -$1.77K 0.02% 233
2016
Q4
$13K Buy
257
+35
+16% +$1.74K 0.02% 237
2016
Q3
$11K Buy
222
+22
+11% +$1.11K 0.02% 250
2016
Q2
$11K Hold
200
0.02% 227
2016
Q1
$10K Sell
200
-53
-21% -$2.39K 0.01% 277
2015
Q4
$11K Sell
253
-24
-9% -$1.03K 0.01% 245
2015
Q3
$12K Sell
277
-5
-2% -$204 0.01% 228
2015
Q2
$11K Buy
282
+10
+4% +$422 0.01% 268
2015
Q1
$12K Buy
272
+25
+10% +$1.14K 0.01% 251
2014
Q4
$11K Sell
247
-37
-13% -$1.62K 0.01% 254
2014
Q3
$11K Buy
284
+5
+2% +$201 0.01% 249
2014
Q2
$12K Hold
279
0.01% 245
2014
Q1
$11K Sell
279
-10
-3% -$370 0.01% 246
2013
Q4
$10K Hold
289
0.01% 280
2013
Q3
$10K Buy
289
+7
+2% +$241 0.01% 274
2013
Q2
$10K Buy
+282
New +$9.98K 0.01% 268

Other funds holding VVC

Weaver C. Barksdale & Associates's VVC Position: Q4 2017 in Review

Weaver C. Barksdale & Associates increased its Vectren Corporation (VVC) stake by 6.4% in Q4 2017, buying an estimated $873 and bringing the position to 217 shares worth $14K. The position accounts for 0.01% of the portfolio, ranked #224.

Weaver C. Barksdale & Associates first reported a position in VVC in Q2 2013 and has held it in 19 quarters since. 365 funds tracked by Wall St. Rank hold VVC as of Q4 2017.

  • Weaver C. Barksdale & Associates held 217 shares of Vectren Corporation worth $14K as of Q4 2017.
  • Weaver C. Barksdale & Associates bought 13 Vectren Corporation shares in Q4 2017, an estimated $873.
  • Vectren Corporation made up 0.01% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #224 holding.
  • Weaver C. Barksdale & Associates first reported a position in Vectren Corporation in Q2 2013 and has held it in 19 quarters since.
  • 365 funds tracked by Wall St. Rank held Vectren Corporation as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.